Translating AI-Enabled Multi-Omics Diagnostics into Clinical Practice: Regulatory, Reimbursement, and Adoption Pathways
Presented by Junmei Cairns, Associate Director at AstraZeneca
Sponsorship Event Briefing: NextGen Omics, Spatial & Data US 2026
Scaling AI-Driven Pathology into Clinical and Commercial Diagnostics
AGENDA OVERVIEW
10 March 2026 – 15.30 to 16.30 UK Time
15.30 Thought Leadership Interview: The Emerging Era of Computational Precision Biomarkers
Eric Walk, Chief Medical Officer, PathAI
15.45 Thought Leadership Interview: Pioneering the Future of Diagnostics: AI and Innovation in Pathology
Dr. Muhammed Aslam, Consultant Pathologist, Betsi Cadwaladr University Health Board; Clinical Lead for Wales Digital Pathology/AI
16.00 Panel Discussion: Computational Precision Biomarkers & Spatial Pathology - The Next Frontier in Precision Diagnostics
- Integrating AI in CDx, spatial pathology, and translational data - Integrating AI in CDx, spatial pathology and how translational data informs diagnosis, prognosis, and treatment strategies.
- Scaling innovation across public and private sectors: collaborations between the NHS, biotech, AI startups, and healthtech; the role of leadership in aligning efforts.
- Opportunities in Precision Biomarkers and Commercialisation
Moderated by Darren Davis, Director, Precision for Medicine
Panellists:
John LE QUESNE, Professor, University of Glasgow
Eric Walk, Chief Medical Officer, PathAI
Muhammed Aslam, Consultant Pathologist, Betsi Cadwaladr University Health Board; Clinical Lead for Wales Digital Pathology/AI
Biography:
Dr M B Aslam is a at Betsi Cadwaladr University Health Board with a special interest in digital pathology and artificial intelligence. He has played a key leadership role in the development and implementation of AI-enabled diagnostic services across Wales, including pioneering national deployment projects in prostate, breast, upper GI, and pan-cancer pathology.
With extensive experience in clinical leadership and NHS management, Dr Aslam currently serves as the national clinical lead for digital pathology and AI in Wales. His work focuses on enhancing diagnostic quality, reducing turnaround times, and supporting the digital transformation of pathology services.
